Aerogen

Novel pharmaceutical products based on proprietary aerosolization technology for treatment of respiratory disorders in the critical care setting and inhalation systems for pulmonary delivery of insulin. Aerogen completed an IPO in November 2000 and was acquired by Nektar in October 2005.

USVP Contact:

Phil Young

print version

Bayhill Therapeutics

Biopharmaceutical company developing therapies for the treatment of autoimmune diseases, including multiple sclerosis and Type I diabetes, based on technologies that originated in Prof. Lawrence Steiman, M.D.'s laboratory at Stanford.

USVP Contact:

Phil Young and Jon Root

print version

CardioKinetix

Medical implants that treat ventricular wall motion abnormalities which occur after an AMI and can progress to end-stage heart failure.

USVP Contact:

Casey Tansey

print version

Castlight Health

Comparison shopping tool for healthcare services

USVP Contact:

Jon Root

print version

Devax

Developing a coronary stent to treat atherosclerotic lesions at bifurcations in the coronaries, an unsolved problem in interventional cardiology.

USVP Contact:

Casey Tansey

print version

Ilypsa

Ilypsa (acquired by Amgen) is a therapeutics platform spinout of Symx that develops novel polymer-based, orally bioavailable therapies to treat renal failure and metabolic disorders.

USVP Contact:

Jon Root

print version

Intellikine

A leader in the discovery and development of novel, small molecule therapies targeting the PI3K/Akt/mTOR pathway for treatment of cancer, inflammation, and autoimmune diseases.

USVP Contact:

Larry Lasky and Jon Root

print version

Intersect ENT (formerly Sinexus)

Medical device company

USVP Contact:

Casey Tansey

print version

Intuity Medical

A medical device company.

USVP Contact:

Casey Tansey

print version

Lutonix

Developing a novel catheter system to treat coronary and peripheral arterial stenosis caused by atherosclerosis

USVP Contact:

Jon Root

print version

Matritech

Matritech (acquired by Inverness Medical) is a leading developer of proteomics-based diagnostic products for the early detection of cancer. Using its patented proteomics technology, Matritech has identified proteins correlated with bladder, cervical, breast, prostate and colon cancers.

USVP Contact:

Phil Young

print version

MicroHeart

MicroHeart (acquired by Boston Scientific) develops drug delivery systems for angiogenesis.

USVP Contact:

Phil Young

print version

MicroVention

MicroVention (acquired by Terumo Medical) is a rapidly growing medical device company pioneering the development of catheter-based technologies for the endovascular treatment of peripheral and cerebral vascular diseases.

USVP Contact:

Jon Root

print version

OncoMed Pharmaceuticals

Developing innovative pharmaceuticals for solid tumors, based on the recent identification of cancer stem cells.

USVP Contact:

Jon Root

print version

Proteolix

Proteolix (acquired by Onyx > Pharmaceuticals) is a biopharmaceutical company committed to the discovery, clinical development and marketing of drugs that inhibit the proteasome-mediated protein degradation pathway in cells for the treatment of cancer.

USVP Contact:

Jon Root

print version

RelayHealth

RelayHealth (acquired by McKesson) offers web-based communication services that connect doctors and their patients efficiently, affordably, and securely.

USVP Contact:

Phil Young and Jon Root

print version

Sanarus Medical

Provides minimally-invasive solutions for the screening, diagnosis and treatment of breast disease, including breast cancers and non-malignant growths.

USVP Contact:

Alan Kaganov

print version

SentreHEART

Developing a minimally invasive device and procedure for isolating the left atrial appendage in patients with atrial fibrillation in order to prevent blood clots that result in embolic strokes.

USVP Contact:

Casey Tansey

print version

Sequent Medical

Developing novel devices for the treatment of vascular diseases.

USVP Contact:

Jon Root

print version

Simpirica Spine

Developing devices to treat medical conditions in the spine

USVP Contact:

Phil Young

print version

Synarc

Provides advanced medical imaging and biochemical macher services to the pharmaceutical industry in the conduct of clinical trials using imaging as end points.

USVP Contact:

Phil Young

print version

Ventritex

Ventritex (acquired by St. Jude Medical) manufactures mechanical and tissue heart valves, pacemakers, implantable cardioverter defibrillators and electrophysiology catheters.

USVP Contact:

Bill Bowes

print version

Talima Therapeutics

Developing a novel bio-erodible implant for the treatment of onychomycosis (toe nail fungus).

USVP Contact:

Phil Young

print version

Valeritas

Medical technology company serving the fast-growing diabetes market through its proprietary drug delivery systems

USVP Contact:

Jonathan Root

print version

Vontu

Vontu (acquired by Symantec) is the industry's first data loss prevention solution that stops confidential and classified information, including customer data and intellectual property, from being sent outside the corporate network.

USVP Contact:

Steve Krausz

print version

Xoma (XOMA)

Develops biopharmaceuticals that target cancer, immunological disorders and infectious diseases. Its product, RAPTIVA, is the first FDA-approved biologic therapy designed to provide continuous control of chronic moderate-to-severe plaque psoriasis.

USVP Contact:

Bill Bowes

print version

Copyright © 2011 U.S. Venture Partners. All Rights Reserved. USVP and Venture Partners are registered trademarks of USVP Management Company LLC.